Ross Cameron
Impact in
- Hepatology top 1%
- Liver Disease and Transplantation
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Hepatology 29
- Liver Disease and Transplantation 10
- Hepatitis C virus research 9
- Liver Diseases and Immunity 7
- Epidemiology 24
- Liver Disease Diagnosis and Treatment 20
- Co-authors
- Emmanuel Farber (16 shared papers)Gary Levy (17 shared papers)Manuela G. Neuman (10 shared papers)Douglas M. Templeton (5 shared papers)Laurence M. Blendis (12 shared papers)Paul D. Greig (15 shared papers)Robert A. McClelland (2 shared papers)Gary M. Brittenham (2 shared papers)
- Journals
- Clinical Biochemistry (5 papers)Cancer Letters (4 papers)Toxicologic Pathology (4 papers)Gastroenterology (4 papers)Carcinogenesis (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Ross Cameron
101 papers receiving 4.1k citations
Ross Cameron's Hit Papers
Peers
Comparison fields: 5 of 148
- Hepatology 819
- Pharmacology 563
- Genetics 560
- Hematology 467
- Cancer Research 545
Countries citing papers authored by Ross Cameron
This map shows the geographic impact of Ross Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Cameron more than expected).
Fields of papers citing papers by Ross Cameron
This network shows the impact of papers produced by Ross Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Cameron. The network helps show where Ross Cameron may publish in the future.
Co-authors
The 25 scholars most cited alongside Ross Cameron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Sequential Analysis of Cancer Development Hit paper breakdown → | 1980 | 488 |
| 2 | 1998 | 304 | |
| 3 | 1995 | 256 | |
| 4 | Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis. | 1978 | 174 |
| 5 | 1991 | 154 | |
| 6 | 1989 | 126 | |
| 7 | 1993 | 115 | |
| 8 | 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. | 2000 | 113 |
| 9 | A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo(a)pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. | 1976 | 108 |
| 10 | 1992 | 105 | |
| 11 | 1990 | 95 | |
| 12 | A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. | 2000 | 94 |
| 13 | Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine. | 1982 | 85 |
| 14 | Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. | 2006 | 81 |
| 15 | 1999 | 79 | |
| 16 | 1995 | 65 | |
| 17 | Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. | 2003 | 61 |
| 18 | 1986 | 61 | |
| 19 | 1991 | 59 | |
| 20 | 2007 | 57 |
About Ross Cameron
Ross Cameron is a scholar working on Hepatology, Epidemiology, Pharmacology, Molecular Biology and Cancer Research, having authored 102 papers that have together received 4.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (20 papers), Pharmacogenetics and Drug Metabolism (12 papers), Liver Disease and Transplantation (10 papers), Hepatitis C virus research (9 papers), Glutathione Transferases and Polymorphisms (8 papers), Alcohol Consumption and Health Effects (7 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Liver Diseases and Immunity (7 papers). The work is most often cited by research in Hepatology (819 citations), Pharmacology (563 citations), Genetics (560 citations), Hematology (467 citations) and Cancer Research (545 citations). Ross Cameron has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Emmanuel Farber, Gary Levy, Manuela G. Neuman, Douglas M. Templeton, Laurence M. Blendis, Paul D. Greig, Robert A. McClelland, Gary M. Brittenham, Katherine A. Vallis and Ian R. Wanless. Their work appears in journals such as Clinical Biochemistry, Cancer Letters, Toxicologic Pathology, Gastroenterology and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.